BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37909877)

  • 1. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
    Oeffinger KC; Fontham ET; Etzioni R; Herzig A; Michaelson JS; Shih YC; Walter LC; Church TR; Flowers CR; LaMonte SJ; Wolf AM; DeSantis C; Lortet-Tieulent J; Andrews K; Manassaram-Baptiste D; Saslow D; Smith RA; Brawley OW; Wender R;
    JAMA; 2015 Oct; 314(15):1599-614. PubMed ID: 26501536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Cancer Society lung cancer screening guidelines.
    Wender R; Fontham ET; Barrera E; Colditz GA; Church TR; Ettinger DS; Etzioni R; Flowers CR; Gazelle GS; Kelsey DK; LaMonte SJ; Michaelson JS; Oeffinger KC; Shih YC; Sullivan DC; Travis W; Walter L; Wolf AM; Brawley OW; Smith RA
    CA Cancer J Clin; 2013; 63(2):107-17. PubMed ID: 23315954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
    Hendrick RE; Smith RA
    Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
    White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
    Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study.
    Meza R; Cao P; de Nijs K; Jeon J; Smith RA; Ten Haaf K; de Koning H
    Cancer; 2024 Jan; 130(2):244-255. PubMed ID: 37909874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
    Landy R; Cheung LC; Young CD; Chaturvedi AK; Katki HA
    Cancer; 2024 Jan; 130(2):201-215. PubMed ID: 37909885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
    Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
    Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.